בוקולאם 5 מ"ג

Land: Israel

Sprache: Hebräisch

Quelle: Ministry of Health

Wirkstoff:

MIDAZOLAM AS HYDROCHLORIDE 5 MG

Verfügbar ab:

NEOPHARM CURE (2005) LTD

ATC-Code:

N05CD08

Darreichungsform:

OROMUCOSAL SOLUTION

Verabreichungsweg:

BUCCAL

Hergestellt von:

SCM PHARMA LIMITED, UK

Therapiegruppe:

MIDAZOLAM

Anwendungsgebiete:

Treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents (from 3 months to < 18 years). Buccolam must only be used by parents/carers where the patient has been diagnosed to have epilepsy. For infants between 3-6 months of age treatment should be in a hospital setting where monitoring is possible and resuscitation equipment is available.

Berechtigungsdatum:

2013-05-01